181 related articles for article (PubMed ID: 25866901)
1. The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport.
Trevaskis NL; Hu L; Caliph SM; Han S; Porter CJ
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25866901
[TBL] [Abstract][Full Text] [Related]
2. A single-day mouse mesenteric lymph surgery in mice: an updated approach to study dietary lipid absorption, chylomicron secretion, and lymphocyte dynamics.
Dedousis N; Teng L; Kanshana JS; Kohan AB
J Lipid Res; 2022 Nov; 63(11):100284. PubMed ID: 36152881
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Lymph Collection via Cannulation of the Mesenteric Lymphatic Duct in Mice.
Banan B; Wei Y; Simo O; Tso P; Abumrad NN; Flynn CR; Sundaresan S; Albaugh VL
J Surg Res; 2021 Apr; 260():399-408. PubMed ID: 33261855
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
[TBL] [Abstract][Full Text] [Related]
5. Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.
Han S; Quach T; Hu L; Lim SF; Zheng D; Leong NJ; Sharma G; Bonner D; Simpson JS; Trevaskis NL; Porter CJH
Mol Pharm; 2023 May; 20(5):2675-2685. PubMed ID: 36996486
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic lipid transport is not impaired in ageing rat intestine.
Hayashi H; Sato Y; Kanai S; Masuda M; Ohta M; Funakoshi A; Nagao K; Imaizumi K; Miyasaka K
Mech Ageing Dev; 2000 Feb; 113(3):219-25. PubMed ID: 10714940
[TBL] [Abstract][Full Text] [Related]
7. A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: Cannulation of the mesenteric and thoracic lymph ducts within the rat.
Boyd M; Risovic V; Jull P; Choo E; Wasan KM
J Pharmacol Toxicol Methods; 2004; 49(2):115-20. PubMed ID: 14990336
[TBL] [Abstract][Full Text] [Related]
8. Ezetimibe inhibits lymphatic transport of esterified cholesterol but not free cholesterol in thoracic lymph duct-cannulated rats.
Shirouchi B; Nakamura Y; Furukawa Y; Shiraishi A; Tomoyori H; Imaizumi K; Sato M
Cardiovasc Drugs Ther; 2012 Oct; 26(5):427-31. PubMed ID: 22798197
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model.
Seeballuck F; Lawless E; Ashford MB; O'Driscoll CM
Pharm Res; 2004 Dec; 21(12):2320-6. PubMed ID: 15648264
[TBL] [Abstract][Full Text] [Related]
10. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.
Caliph SM; Charman WN; Porter CJ
J Pharm Sci; 2000 Aug; 89(8):1073-84. PubMed ID: 10906731
[TBL] [Abstract][Full Text] [Related]
11. Effect of polydextrose on absorption of triglyceride and cholesterol in mesenteric lymph-fistula rats.
Ogata S; Fujimoto K; Iwakiri R; Matsunaga C; Ogawa Y; Koyama T; Sakai T
Proc Soc Exp Biol Med; 1997 May; 215(1):53-8. PubMed ID: 9142137
[TBL] [Abstract][Full Text] [Related]
12. Acute hypertriglyceridemia promotes intestinal lymphatic lipid and drug transport: a positive feedback mechanism in lipid and drug absorption.
Trevaskis NL; Charman WN; Porter CJ
Mol Pharm; 2011 Aug; 8(4):1132-9. PubMed ID: 21604764
[TBL] [Abstract][Full Text] [Related]
13. Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats.
Cai Q; Deng X; Li Z; An D; Shen T; Zhong M
Drug Deliv; 2016; 23(1):147-53. PubMed ID: 24786483
[TBL] [Abstract][Full Text] [Related]
14. Acute small intestinal inflammation results in persistent lymphatic alterations.
Rehal S; Stephens M; Roizes S; Liao S; von der Weid PY
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G408-G417. PubMed ID: 29351397
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system.
Lee JB; Zgair A; Malec J; Kim TH; Kim MG; Ali J; Qin C; Feng W; Chiang M; Gao X; Voronin G; Garces AE; Lau CL; Chan TH; Hume A; McIntosh TM; Soukarieh F; Al-Hayali M; Cipolla E; Collins HM; Heery DM; Shin BS; Yoo SD; Kagan L; Stocks MJ; Bradshaw TD; Fischer PM; Gershkovich P
J Control Release; 2018 Sep; 286():10-19. PubMed ID: 30016732
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs.
Dahan A; Hoffman A
Eur J Pharm Sci; 2005 Mar; 24(4):381-8. PubMed ID: 15734305
[TBL] [Abstract][Full Text] [Related]
17. Organ-specific lymphatics play distinct roles in regulating HDL trafficking and composition.
Gracia G; Cao E; Johnston APR; Porter CJH; Trevaskis NL
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G725-G735. PubMed ID: 32068443
[TBL] [Abstract][Full Text] [Related]
18. Intestinal lymphatic drug transport: an update.
Porter CJ; Charman WN
Adv Drug Deliv Rev; 2001 Aug; 50(1-2):61-80. PubMed ID: 11489334
[TBL] [Abstract][Full Text] [Related]
19. Obesity-associated mesenteric lymph leakage impairs the trafficking of lipids, lipophilic drugs and antigens from the intestine to mesenteric lymph nodes.
Mikrani R; Styles IK; Hoang TA; Abdallah M; Senyschyn D; Porter CJH; Cao E; Trevaskis NL
Eur J Pharm Biopharm; 2022 Nov; 180():319-331. PubMed ID: 36283633
[TBL] [Abstract][Full Text] [Related]
20. Effects of intestinal lymphatic ligation on intestinal immunity in rats with severe acute pancreatitis.
Liu Y; Chen L; Wang L; Xiong Y
FEBS Open Bio; 2021 Apr; 11(4):1109-1121. PubMed ID: 33576136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
